Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma

NCT04339218 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

214

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma
Cryotherapy Effect

Interventions

DEVICE: Cryoablation
DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Institut Bergonié